nach oben

PharmacoEconomics

Erschienen in:

01.04.2014 | Editorial

Achieving Allocative Efficiency in Healthcare: Nice in Theory, not so NICE in Practice?

verfasst von: Mike Paulden, Christopher McCabe, Jonathan Karnon

Erschienen in: PharmacoEconomics | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Excerpt

Eckermann and Pekarsky [15] have written a thought-provoking paper that challenges a number of existing concepts, including methods for determining the cost-effectiveness threshold for appraising new health technologies for potential adoption into a public healthcare system. …

McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics. 2008;26(9):733–44. http://www.ncbi.nlm.nih.gov/pubmed/18767894. Accessed 2 Dec 2010.

Claxton K, Briggs A, Buxton MJ, et al. Value based pricing for NHS drugs: an opportunity not to be missed? BMJ. 2008;336(7638):251–4.PubMedCentralPubMedCrossRef

Sculpher M, Claxton K. Real economics needs to reflect real decisions: a response to Johnson. Pharmacoeconomics. 2012;30(2):133–6. doi:10.2165/11596660-000000000-00000.PubMedCrossRef

Griffin S, Claxton K, Sculpher M. Decision analysis for resource allocation in health care. J Health Serv Res Policy. 2008;13(Suppl 3):23–30. doi:10.1258/jhsrp.2008.008017.PubMedCrossRef

Culyer A, McCabe C, Briggs A, et al. Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. J Health Serv Res Policy. 2007;12(1):56–8. doi:10.1258/135581907779497567.PubMedCrossRef

National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. London: NICE; 2013. http://publications.nice.org.uk/pmg9. Accessed 28 Feb 2014.

Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, et al. Methods for the estimation of the NICE cost effectiveness threshold final report, University of York. 2013. http://www.york.ac.uk/media/che/documents/papers/researchpapers/CHERP81_methods_estimation_NICE_costeffectiveness_threshold_%28Nov2013%29.pdf. Accessed 28 Feb 2014.

Garner S, Littlejohns P. Disinvestment from low value clinical interventions: NICEly done? BMJ. 2011;343:d4519. doi:10.1136/bmj.d4519.PubMedCrossRef

Pekarsky B. Trust, constraints and the counterfactual: Reframing the political economy of new drugs. 2012;(April) [thesis]. http://digital.library.adelaide.edu.au/dspace/bitstream/2440/79171/3/02whole.pdf. Accessed 28 Feb 2014.

10.

Elshaug AG, Watt AM, Mundy L, Willis CD. Over 150 potentially low-value health care practices: an Australian study. Med J Aust. 2012;197(10):556–60. doi:10.5694/mja12.11083.PubMedCrossRef

11.

Karnon J, Caffrey O, Pham C, et al. Applying risk adjusted cost-effectiveness (RAC-E) analysis to hospitals: estimating the costs and consequences of variation in clinical practice. Health Econ. 2013;22(6):631–42. doi:10.1002/hec.2828.PubMedCrossRef

12.

ABIM Foundation. Choosing wisely. 2014. http://www.choosingwisely.org/. Accessed 12 Feb 2014.

13.

Institute for Healthcare Improvement. The IHI Triple Aim. 2013. http://www.ihi.org/engage/initiatives/tripleaim/pages/default.aspx. Accessed 28 Feb 2014.

14.

Porter ME. What is value in health care? N Engl J Med. 2010;363(26):2477–81. doi:10.1056/NEJMp1011024.PubMedCrossRef

15.

Eckermann S, Pekarsky B. Can the real opportunity cost stand up: displaced services, the straw man outside the room. Pharmacoeconomics. Epub 2014 Feb. doi:10.1007/s40273-014-0140-3.

Titel: Achieving Allocative Efficiency in Healthcare: Nice in Theory, not so NICE in Practice?
verfasst von: Mike Paulden
Christopher McCabe
Jonathan Karnon
Publikationsdatum: 01.04.2014
Verlag: Springer International Publishing
Erschienen in: PharmacoEconomics / Ausgabe 4/2014
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI: https://doi.org/10.1007/s40273-014-0146-x

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

Methods for Identifying the Cost-effective Case Definition Cut-Off for Sequential Monitoring Tests: An Extension of Phelps and Mushlin

Differential Time Preferences for Money and Quality of Life

Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature

Capturing Disutility from Waiting Time

A Systematic Review of the Quality of Economic Models Comparing Thrombosis Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Treatment Sequencing After Failure of the First Biologic in Cost-Effectiveness Models of Psoriasis: A Systematic Review of Published Models and Clinical Practice Guidelines